Joel Falk is an Executive Vice President at The Weinberg Group. He has responsibility for the management of clinical research, data management, pharmacovigilance and pharmaceutical product defense issues. Mr. Falk has 35 years of experience in the pharmaceutical industry performing a variety of functions including: medical writing, clinical development, design and monitoring, project management, strategic and portfolio management, and due diligence of products and companies. He has either led or been instrumental in more than 20 major drug submissions in the United States and abroad in a variety of therapeutic areas such as: cardiovascular-renal, allergy, pulmonology, infectious disease, CNS and oncolytics, as well as medical devices. Since joining The Weinberg Group, Mr. Falk has been actively involved in managing programs specifically geared toward the problem solving of pharmaceutical issues for large and small drug firms, always with an eye toward enhancing the client’s position. He has spoken at a number of international symposia relating to effective management of clinical projects and new and efficient techniques for data management.